Isoniazid preventive therapy during infancy does not adversely effect growth among HIV-exposed uninfected children: secondary analysis of data from a randomized controlled trial.
Ashenafi Shumey CherkosSylvia M LaCourseDaniel A EnquobahrieJaclyn N EscuderoJerphason MechaDaniel MatemoJohn KinuthiaGrace John-StewartPublished in: medRxiv : the preprint server for health sciences (2023)
IPT administered to HEU infants did not significantly impact growth outcomes in the first two years of life.